State of Wyoming Buys 15,950 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

State of Wyoming raised its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 169.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 25,359 shares of the company’s stock after acquiring an additional 15,950 shares during the quarter. State of Wyoming’s holdings in Option Care Health were worth $588,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp bought a new position in Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. boosted its stake in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC boosted its stake in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new position in Option Care Health in the fourth quarter valued at approximately $47,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Trading Up 2.3%

OPCH opened at $33.23 on Monday. The stock has a market capitalization of $5.44 billion, a P/E ratio of 27.92, a P/E/G ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm’s fifty day simple moving average is $33.07 and its 200 day simple moving average is $29.06. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same period in the previous year, the firm posted $0.26 EPS. The firm’s revenue was up 16.3% compared to the same quarter last year. As a group, research analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on OPCH. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Finally, JMP Securities reissued a “market outperform” rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.